A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.
Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models